LAB
Standard BioTools Inc. · Healthcare
Casdin Partners Master Fund, L.P. bought $636K of Standard BioTools Inc.
Director and 10% owner
Bought$635,750
$1.27Price
500,000Shares
+1%Stake
What LAB did for a copier
- $1,000 copied at Fri, Sep 5 close, $1.30
- $977
- S&P 500, same days
- +2.9%
Measured over 30 trading days, to the Oct 17 close.
Casdin Partners Master Fund, L.P.'s record
18 other buys with 3 months of prices since 2020: on average −10.2% against the S&P 500, and 6 of 18 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Sep 3. Filed Fri, Sep 5, 3:08 PM ET, during the session. Returns use the Sep 5 close and the Oct 17 close. Not investment advice.